Total Stocks
—
Gainers
—
Losers
—
Best Today
—
Worst Today
—
Sector Performance
—
Movers
Trade Date ·
Code ·
Min Turnover · $0
Min Accum · 0
| # | Sector | Code | MCap | Company | Prev Close | Open | Last | Turnover | Chg | Chg % | High | Low | Volume | 2× Vol | RSI | Accum | News |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loading... | |||||||||||||||||
Trade Date
Code
Min Turnover $
Min Sc
Signal
| # | Code | Score | Signal | Chg % | Turnover | Last | 60D Trend | 60D Med % | 10D Win | Vol× | Day Range | Breakdown |
|---|
Trade Date
Code
Min Turnover $
Min Score
Min Mkt Cap ($M)
| # | Code | Company | Mkt Cap | Inst Score | Drivers | Chg % | Turnover | Vol× | 2× Vol | RSI | 14D Avg Gain | 14D Avg Loss | 6D | Day Range | 60D Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loading... | |||||||||||||||
Your One-Stop Destination For
Australian Stocks & ETFs - Trading Data, Announcements and Overview AI-Powered Summaries, Market Insights, Analysis, Signals and Trends
Free research covering 2,300+ ASX-listed companies - with daily price-sensitive announcements distilled by AI, momentum and trend scoring, sector performance tracking, and a powerful full-market screener.
Quick find
AI-Powered Daily Briefing
— shown of
— price-sensitive
— other ·
ranked by likely impact at the open
What you can do here · all of it free, no sign-up
📢Announcements
Every price-sensitive release, summarised.
📊Market Overview
Sector performance and the day's breadth.
🖥Daily Trade Snapshot
Full-market screener over 2,300+ codes.
🎯Momentum
How sustained a move is, not just how big.
🧠Signals
Composite scoring, catalysts and cycle phase.
🎯Advisor
Per-stock deep dive from the same data.
🏢Sectors
Every listed company, grouped by sector.
📊ETFs
Every ASX ETF and ETP, grouped by issuer.
✉Contact
Questions, feedback or a data problem.
Health Care stocks on the ASX
145 ASX-listed health care companies that traded on the latest session, ranked by market capitalisation. Each row shows the momentum quality score (0-100), trend stage and Wyckoff phase calculated independently by Stock Trade Intel. Click any code for the full analysis.
| Code | Company | Market cap | Change | MQS | Trend stage | Wyckoff phase |
|---|---|---|---|---|---|---|
| CSL | CSL Ltd | $65.38B | -0.74% | 48 | Neutral | Uptrend |
| SIG | Sigma Healthcare Ltd | $34.40B | 0.00% | 48 | Neutral | Uptrend |
| FPH | Fisher & Paykel Healthcare Corporation Ltd | $20.77B | +0.28% | 57 | Neutral | Uptrend |
| RMD | Resmed Inc | $18.94B | +0.72% | 46 | Emerging | Accumulation |
| PME | Pro Medicus Ltd | $18.68B | -2.64% | 35 | Neutral | Accumulation |
| SHL | Sonic Healthcare Ltd | $11.06B | -0.13% | 60 | Neutral | Accumulation |
| RHC | Ramsay Health Care Ltd | $10.34B | -0.13% | 61 | Confirmed Uptrend | Uptrend |
| COH | Cochlear Ltd | $8.73B | -0.25% | 49 | Neutral | Accumulation |
| TLX | TELIX Pharmaceuticals Ltd | $5.69B | -3.63% | 47 | Emerging | Uptrend |
| ANN | Ansell Ltd | $4.95B | +0.71% | 64 | Neutral | Uptrend |
| EBO | Ebos Group Ltd | $3.66B | -2.00% | 40 | Breakdown | Downtrend |
| NEU | Neuren Pharmaceuticals Ltd | $2.97B | -0.51% | 60 | Neutral | Uptrend |
| MSB | Mesoblast Ltd | $2.87B | -7.14% | 28 | Emerging | Accumulation |
| 4DX | 4DMEDICAL LIMITED | $2.18B | -6.91% | 24 | Neutral | Accumulation |
| PYC | PYC THERAPEUTICS LIMITED | $2.10B | -0.47% | 62 | Accelerating Trend | Uptrend |
| REG | Regis Healthcare Ltd | $1.87B | +0.82% | 18 | Breakdown | Downtrend |
| RYM | Ryman Healthcare Ltd | $1.74B | -1.44% | 28 | Breakdown | Downtrend |
| SNZ | Summerset Group Holdings Ltd | $1.63B | -1.77% | 25 | Breakdown | Accumulation |
| NAN | Nanosonics Ltd | $1.06B | 0.00% | 33 | Emerging | Accumulation |
| CU6 | Clarity Pharmaceuticals Ltd | $978M | -6.07% | 36 | Emerging | Accumulation |
| IDX | Integral Diagnostics Ltd | $836M | +0.45% | 41 | Emerging | Accumulation |
| AYA | ARTRYA LIMITED | $784M | +2.56% | 42 | Neutral | Accumulation |
| IMR | IMRICOR MEDICAL SYSTEMS INC. | $731M | -0.49% | 43 | Emerging | Uptrend |
| PNV | Polynovo Ltd | $667M | +2.12% | 30 | Emerging | Accumulation |
| CUV | CLINUVEL PHARMACEUTICALS LIMITED | $482M | -0.42% | 26 | Neutral | Accumulation |
| OCA | OCEANIA HEALTHCARE LIMITED | $478M | +0.76% | 53 | Neutral | Accumulation |
| CGS | COGSTATE LTD | $476M | +2.19% | 42 | Emerging | Distribution |
| ACL | AUSTRALIAN CLINICAL LABS LIMITED | $438M | -0.42% | 54 | Neutral | Distribution |
| RAC | RACE ONCOLOGY LTD | $391M | -0.75% | 25 | Neutral | Accumulation |
| SPL | STARPHARMA HOLDINGS LIMITED | $305M | 0.00% | 52 | Neutral | Distribution |
| HLS | Healius Ltd | $290M | -4.76% | 38 | Emerging | Accumulation |
| VFY | VITRAFY LIFE SCIENCES LIMITED | $289M | +11.03% | 60 | Emerging | Uptrend |
| MVF | MONASH IVF GROUP LIMITED | $271M | -0.71% | 24 | Neutral | Accumulation |
| PEB | PACIFIC EDGE LIMITED | $261M | -1.18% | 30 | Neutral | Accumulation |
| MYX | MAYNE PHARMA GROUP LIMITED | $260M | -1.23% | 55 | Neutral | Accumulation |
| PGC | PARAGON CARE LIMITED | $223M | 0.00% | 29 | Neutral | Accumulation |
| EBR | EBR SYSTEMS INC. | $222M | -1.67% | 43 | Neutral | Downtrend |
| OCC | ORTHOCELL LIMITED | $210M | -2.53% | 22 | Emerging | Accumulation |
| ARX | AROA BIOSURGERY LIMITED | $208M | +1.69% | 38 | Emerging | Accumulation |
| TTX | TETRATHERIX LIMITED | $197M | +2.62% | 47 | Neutral | Accumulation |
| AVH | AVITA MEDICAL INC. | $186M | -3.07% | 52 | Emerging | Uptrend |
| AVR | ANTERIS TECHNOLOGIES GLOBAL CORP. | $183M | -1.87% | 40 | Confirmed Uptrend | Accumulation |
| OIL | OPTISCAN IMAGING LIMITED | $178M | -5.56% | 67 | Accelerating Trend | Uptrend |
| DXB | DIMERIX LIMITED | $177M | 0.00% | 43 | Neutral | Accumulation |
| NYR | NYRADA INC. | $173M | -1.41% | 44 | Emerging | Accumulation |
| ACW | ACTINOGEN MEDICAL LIMITED | $165M | -2.17% | 31 | Emerging | Accumulation |
| EMV | EMVISION MEDICAL DEVICES LTD | $165M | +2.60% | 26 | Emerging | Accumulation |
| SLD | Saluda Medical, Inc | $158M | -3.85% | 36 | Emerging | Accumulation |
| ONE | ONEVIEW HEALTHCARE PLC | $138M | +3.13% | 33 | Breakdown | Accumulation |
| VLS | VITA LIFE SCIENCES LIMITED.. | $133M | -1.61% | 24 | Breakdown | Downtrend |
| ILA | ISLAND PHARMACEUTICALS LIMITED | $130M | -4.35% | 35 | Emerging | Accumulation |
| ALC | ALCIDION GROUP LIMITED | $121M | -1.10% | 26 | Neutral | Accumulation |
| ATH | ALTERITY THERAPEUTICS LIMITED | $119M | +1.87% | 46 | Neutral | Accumulation |
| RCE | RECCE PHARMACEUTICALS LTD | $113M | -1.33% | 23 | Neutral | Accumulation |
| PAR | PARADIGM BIOPHARMACEUTICALS LIMITED.. | $108M | 0.00% | 33 | Emerging | Accumulation |
| LDX | LUMOS DIAGNOSTICS HOLDINGS LIMITED | $104M | -4.35% | 34 | Emerging | Accumulation |
| BB1 | BLINKLAB LIMITED | $103M | -0.74% | 37 | Emerging | Accumulation |
| PTX | PRESCIENT THERAPEUTICS LIMITED | $90M | +3.61% | 51 | Neutral | Accumulation |
| LTP | LTR PHARMA LIMITED | $89M | -5.77% | 26 | Neutral | Accumulation |
| AHC | AUSTCO HEALTHCARE LIMITED | $88M | +2.17% | 28 | Emerging | Accumulation |
| AVE | AVECHO BIOTECHNOLOGY LIMITED | $77M | 0.00% | 46 | Neutral | Accumulation |
| IMM | IMMUTEP LIMITED | $76M | 0.00% | 21 | Emerging | Accumulation |
| ALA | AROVELLA THERAPEUTICS LIMITED | $75M | +3.33% | 30 | Neutral | Accumulation |
| ATX | AMPLIA THERAPEUTICS LIMITED | $74M | 0.00% | 35 | Emerging | Accumulation |
| SOM | SOMNOMED LIMITED | $73M | -10.81% | 26 | Breakdown | Downtrend |
| EPI | Epiminder Ltd | $66M | +10.29% | 40 | Emerging | Accumulation |
| M7T | MACH7 TECHNOLOGIES LIMITED | $66M | 0.00% | 23 | Breakdown | Downtrend |
| CYC | CYCLOPHARM LIMITED | $65M | -0.96% | 26 | Breakdown | Downtrend |
| BOT | Botanix Pharmaceuticals Ltd | $60M | 0.00% | 17 | Neutral | Accumulation |
| LGP | LITTLE GREEN PHARMA LTD | $60M | -4.00% | 28 | Breakdown | Downtrend |
| SHG | SINGULAR HEALTH GROUP LTD | $60M | 0.00% | 16 | Breakdown | Downtrend |
| ENP | Entropy Neurodynamics Ltd | $59M | 0.00% | 42 | Neutral | Accumulation |
| MVP | MEDICAL DEVELOPMENTS INTERNATIONAL LIMITED | $51M | -1.09% | 48 | Breakdown | Downtrend |
| SNT | SYNTARA LIMITED | $51M | 0.00% | 32 | Neutral | Accumulation |
| NUZ | NEURIZON THERAPEUTICS LIMITED | $48M | +1.64% | 20 | Neutral | Accumulation |
| RAD | RADIOPHARM THERANOSTICS LIMITED | $48M | -8.33% | 31 | Breakdown | Downtrend |
| COV | CLEO DIAGNOSTICS LTD | $47M | -4.17% | 30 | Neutral | Accumulation |
| HMD | HERAMED LIMITED | $44M | -2.56% | 25 | Emerging | Accumulation |
| EYE | NOVA EYE MEDICAL LIMITED | $41M | -6.45% | 43 | Emerging | Uptrend |
| DOC | DOCTOR CARE ANYWHERE GROUP PLC | $40M | +4.76% | 24 | Neutral | Accumulation |
| IMU | IMUGENE LIMITED | $40M | -1.20% | 20 | Neutral | Accumulation |
| OSL | Oncosil Medical Ltd | $39M | +0.79% | 51 | Neutral | Accumulation |
| EMD | EMYRIA LIMITED | $38M | +2.17% | 31 | Breakdown | Downtrend |
| CTS | Ceretas Ltd | $34M | +2.94% | — | — | — |
| MAP | MICROBA LIFE SCIENCES LIMITED | $34M | 0.00% | 33 | Emerging | Accumulation |
| CC5 | CLEVER CULTURE SYSTEMS LIMITED | $33M | +7.14% | 26 | Neutral | Accumulation |
| BMT | BEAMTREE HOLDINGS LIMITED | $32M | 0.00% | 18 | Breakdown | Downtrend |
| NC6 | NANOLLOSE LIMITED | $32M | +4.00% | 43 | Emerging | Distribution |
| VHL | VITASORA HEALTH LIMITED | $30M | +8.33% | 28 | Emerging | Accumulation |
| CSX | CLEANSPACE HOLDINGS LIMITED | $29M | -7.50% | 33 | Breakdown | Downtrend |
| RHY | RHYTHM BIOSCIENCES LIMITED | $29M | 0.00% | 28 | Neutral | Accumulation |
| TRJ | TRAJAN GROUP HOLDINGS LIMITED | $29M | 0.00% | 27 | Neutral | Accumulation |
| DVL | DORSAVI LTD | $28M | 0.00% | 19 | Neutral | Accumulation |
| ENL | ENLITIC INC. | $28M | 0.00% | 27 | Breakdown | Downtrend |
| IIQ | INOVIQ LTD | $27M | +2.63% | 17 | Neutral | Accumulation |
| PIQ | PROTEOMICS INTERNATIONAL LABORATORIES LTD | $27M | -1.82% | 31 | Emerging | Accumulation |
| CBL | CONTROL BIONICS LIMITED | $26M | -1.67% | 24 | Breakdown | Downtrend |
| NOX | NOXOPHARM LIMITED | $25M | -2.44% | 24 | Distribution | Accumulation |
| RHT | RESONANCE HEALTH LIMITED | $25M | 0.00% | 54 | Neutral | Accumulation |
| NSB | NEUROSCIENTIFIC BIOPHARMACEUTICALS LTD | $23M | -3.33% | 23 | Neutral | Accumulation |
| 1AI | ALGORAE PHARMACEUTICALS LIMITED | $22M | 0.00% | 23 | Breakdown | Downtrend |
| AGN | ARGENICA THERAPEUTICS LIMITED | $22M | 0.00% | 37 | Emerging | Uptrend |
| EZZ | EZZ LIFE SCIENCE HOLDINGS LIMITED | $22M | -1.06% | 27 | Breakdown | Downtrend |
| IPD | IMPEDIMED LIMITED | $22M | +20.00% | 29 | Emerging | Accumulation |
| NXN | Nexsen Ltd | $22M | +4.35% | 30 | Distribution | Accumulation |
| BDX | BCAL DIAGNOSTICS LIMITED | $21M | +1.82% | 21 | Breakdown | Downtrend |
| MX1 | MICRO-X LIMITED | $21M | -3.45% | 28 | Neutral | Accumulation |
| PAB | PATRYS LIMITED | $21M | -3.13% | 28 | Breakdown | Downtrend |
| PCK | PAINCHEK LTD | $21M | 0.00% | 26 | Neutral | Accumulation |
| PKP | Peak Processing Ltd | $20M | 0.00% | 18 | Neutral | Accumulation |
| IDT | IDT AUSTRALIA LIMITED | $19M | -6.38% | 35 | Emerging | Accumulation |
| MEM | MEMPHASYS LIMITED. | $19M | -14.29% | 31 | Distribution | Accumulation |
| NTI | NEUROTECH INTERNATIONAL LIMITED | $19M | +7.69% | 27 | Breakdown | Downtrend |
| CQT | Conneqt Health Ltd | $17M | 0.00% | 26 | Neutral | Accumulation |
| IME | IMEXHS LIMITED | $17M | -3.13% | 31 | Neutral | Accumulation |
| CYV | Ceryvyn Therapeutics Ltd | $16M | 0.00% | — | — | — |
| TRI | TRIVARX LTD | $16M | -6.67% | 22 | Neutral | Accumulation |
| AT1 | ATOMO DIAGNOSTICS LIMITED | $15M | -5.56% | 25 | Neutral | Accumulation |
| GSS | GENETIC SIGNATURES LIMITED | $13M | +1.72% | 21 | Neutral | Accumulation |
| TRU | TRUSCREEN GROUP LIMITED | $12M | -8.33% | 15 | Breakdown | Downtrend |
| RNV | RENERVE LIMITED | $11M | 0.00% | 25 | Neutral | Accumulation |
| UWC | UNDERWOOD CAPITAL LIMITED | $11M | +10.00% | 37 | Neutral | Accumulation |
| AHE | Adheris Health Ltd | $10M | 0.00% | 20 | Distribution | Accumulation |
| VBS | VECTUS BIOSYSTEMS LIMITED | $10M | 0.00% | 29 | Emerging | Accumulation |
| CVB | CURVEBEAM AI LIMITED | $9M | 0.00% | 31 | Neutral | Accumulation |
| EPN | EPSILON HEALTHCARE LIMITED | $9M | 0.00% | 30 | Breakdown | Accumulation |
| IXC | INVEX THERAPEUTICS LTD | $9M | 0.00% | 28 | Emerging | Accumulation |
| 1AD | ADALTA LIMITED | $8M | 0.00% | 14 | Neutral | Accumulation |
| CTQ | CARETEQ LIMITED | $8M | 0.00% | 38 | Neutral | Accumulation |
| FRE | FIREBRICK PHARMA LIMITED | $8M | 0.00% | 26 | Neutral | Accumulation |
| PER | PERCHERON THERAPEUTICS LIMITED | $8M | +25.00% | 27 | Emerging | Accumulation |
| ACR | ACRUX LIMITED | $6M | 0.00% | 18 | Neutral | Accumulation |
| BIT | BIOTRON LIMITED | $6M | 0.00% | 18 | Neutral | Downtrend |
| HIQ | HITIQ LIMITED | $6M | +20.00% | 25 | Breakdown | Downtrend |
| IBX | IMAGION BIOSYSTEMS LIMITED | $6M | -8.33% | 22 | Neutral | Accumulation |
| ADR | ADHERIUM LIMITED | $5M | -9.09% | 33 | Neutral | Accumulation |
| CAN | CANN GROUP LIMITED | $5M | 0.00% | 29 | Neutral | Accumulation |
| RGT | ARGENT BIOPHARMA LIMITED | $5M | +5.26% | 24 | Breakdown | Downtrend |
| TD1 | TALI DIGITAL LIMITED | $5M | +9.89% | 39 | Emerging | Accumulation |
| GLH | GLOBAL HEALTH LIMITED | $4M | -7.69% | 35 | Breakdown | Accumulation |
| IVX | INVION LIMITED | $4M | +2.56% | 31 | Breakdown | Downtrend |
| ANR | ANATARA LIFESCIENCES LTD | $3M | 0.00% | 15 | Breakdown | Downtrend |
| CYP | CYNATA THERAPEUTICS LIMITED | $3M | 0.00% | 24 | Neutral | Accumulation |
| CHM | CHIMERIC THERAPEUTICS LIMITED | $2M | -12.50% | 28 | Confirmed Uptrend | Accumulation |
| OSX | OSTEOPORE LIMITED | $2M | 0.00% | 18 | Breakdown | Downtrend |
Ann Date ·
Code ·
Min Turnover · $0
Signal
Confidence
Verdict
| # | Time | Sector | Code | Chk | MCap | Company | Announcement Heading | AI Summary | MQS | D% | W% | M% | Y% | Signal | Opportunity | Verdict | Confidence | Turnover | PrvClose-Open-Last | YTD Range | Day Range | 10D News Links | 2× Vol | RSI | 14D Avg Gain | 14D Avg Loss | 60D % Trend | 60D $ Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loading... | ||||||||||||||||||||||||||||
Trade Date ·
Code ·
Min Turnover · $20K
| # | Date | Code | MCap | Company | Chg % | Turnover | Volume | PrvClose-Open-Last | Day Range | Last | Day Low-High | Announcements | Sensitive | AI Summary |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Trade Date ·
50
Min MQS
DaysInPhase ≥ 0
Code
$10K
Min Turnover
📖 Read Me · Momentum
📖 HOW TO READ · MOMENTUM
Every stock scored on how WELL-FORMED its trend is, ranked by MQS (Momentum Quality Score, 0-100). This is the "quality of the trend" screen, not the "biggest mover today" screen.
📊 MQS - the ranking score
Blends moving-average stacking (20>50>100>200), trend consistency, how straight the trend is (R²), volume backing, trend age, low volatility and shallow drawdown into one 0-100 number.
BANDS 80+ exceptional · 65-79 strong · 50-64 moderate · 35-49 weak · under 35 no clear trend. The filter row opens at Min MQS 50.
GOODThe scale is harsher than it looks - on a normal day nothing scores 80+ and most of the market sits under 50. MQS 65 is genuinely strong.
WATCHHigh MQS means a CLEAN trend, not a big one. A 75-MQS stock can be near the end of its run - pair it with the Signals tab's Opportunity Score for timing.
📋 The table, by column group
PRICE MCap · Company · YTD Range (1yr low / now / high) · Day Range (today's low / last / high) · Price · Turnover
RETURN D% · W% · M% · Y% - day, week, month and year change, green up / red down
TREND MQS · Trend Stage · Trend Age · Dur (days above the 50-day average) · R² (how straight, 1.00 = a perfect line) · % of 52W High
RISK ATR% (typical daily move) · MaxDD (worst 60-day drawdown) · RSI · MACD H · Vol× (20d vs 60d volume) · Avg Vol · Inst Accum
CYCLE Phase (daily Wyckoff) · DaysIn (days in that phase) · Weekly (higher timeframe) - green Weekly means both agree, the strongest confirmation here
▸ Insights - the collapsible panel above the table
Eight "best of" tiles, three watchlists (Momentum Leaders / Emerging / Weakening) and sector rankings by average MQS.
IT FOLLOWS YOUR FILTERS. Narrow the table - Min Turnover, sector, phase - and every tile and list re-picks from that same set. The one exception is the "top decile" thresholds behind Momentum Leaders, which stay measured against the whole market so the bar does not move as you filter.
GOODSet Min Turnover to something you would actually trade before reading the tiles. They are max/min picks, so a wide-open filter lets a barely-traded stock win on a technicality.
WATCHA tile can read "- no candidate -" once you filter hard. That is honest, not broken: nothing in your selection met that tile's gate.
🔍 Working the screen
Click any row for the full detail modal. Click a column header to sort. Hover almost anything for a tooltip.
GOODMQS 65+ · Trend Stage "Confirmed Uptrend" · Phase Uptrend · green Weekly. That combination is the highest-conviction long this screen can express.
WATCHA high MQS with RSI above 75 and price hard against the 52-week high is a good stock at a poor moment. Wait for a pullback.
Quality is not upside. Everything here measures how orderly a trend has been, which is a statement about the past. It tells you what to consider, never when to buy.
Esc or click anywhere outside to close
| # | Sector | Code | MCap | Company | YTD Range | Day Range | Price | Turnover | D% | W% | M% | Y% | MQS | Confidence | Trend Stage | Trend Age | Dur | R² | ATR% | MaxDD | RSI | MACD H | Vol× | % of 52W High | Avg Vol | Risk | Inst Accum | Phase | DaysIn | Weekly |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loading... | ||||||||||||||||||||||||||||||
Trade Date ·
Code ·
Min Inv · 50
Min Turnover · $5K
Top 100 · Investment Score
Blend
Top 100 · Opportunity Score
1-10 days
Top 100 · Catalyst Score
Announcement
Top 100 · Unusual Activity
Volume + range
Top 100 · Early Discovery
Before it's obvious
Sector Rankings
🔎 Code / Company ·
Trade Date ·
Assessment inputs: Wyckoff · Inv Score · Outlook · RS · Catalyst · Trend · Risk
Trade Date ·
Code ·
Min Score · 0
| # | Date | Exchange | Code | Mkt Cap | Company | Prev-Open-Cur | Day Range | Chg % | Turnover | Volume |
|---|---|---|---|---|---|---|---|---|---|---|
Loading... | ||||||||||
Code ·
Min Turnover · $20K
Min 5D+
Loading... |
| # | Account | Broker | Code | Company | Mkt Cap | Buy Date | Units | Cost Basis | Prev Close | Last | Chg % | Volume | Turnover | Total Return % | Days Held | Portfolio Cost | Portfolio Value | Profit/Loss | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Loading... | ||||||||||||||||||||||||||
Loading... |
Get in touch
Questions, ideas, a data problem you've spotted, or a business proposal - it all arrives in the same place. We read everything.
💰 Admin Buy
$20,000
📖 Read Me
ADMIN BUY - HOW TO READ THIS
What this tab is
A ranked shortlist for a buy-today / sell-tomorrow hold. It is not a recommendation and not a prediction. End-of-day data carries no reliable overnight edge - tested across 510 liquid ASX stocks and 120,088 three-day sequences, no simple daily price pattern produced an edge that survived transaction costs. The value is in what gets excluded, not in the ranking.
The ranking is provisional
The score was rebuilt from measurement on 2026-07-30 after the original version tested as inverted - ranking by it was worse than random. The replacement has a real edge on 16 days of data (+0.72% between top and bottom decile, ~+0.47% after costs), but that is 16 days of one market regime, and it is a mean-reversion signal: it will fail in a sustained downtrend. It also shows up as a broad decile tilt, not reliably in the top few names - the top 20 beat the market on only 7 of 16 days. Treat the ordering as a mild lean, not a shortlist of best ideas.
Why the list is short
Each gate removes trades that cannot work regardless of how good the setup looks. Typical run: 2,511 → ~645, of which ~300 are tradable at $20k.
| Excluding ETFs | you are picking stocks; ETFs behave differently |
| Price ≥ $0.20 | below this the tick size alone costs ~0.5-1% each way |
| Traded that day | excludes halts and suspensions |
| ATR% ≥ 2 | the daily range must beat brokerage + spread, or the trade cannot pay |
| RSI ≤ 78 | not already exhausted |
| Gap within ±8% | avoids chasing a move that already happened |
| Liquidity | position ≤ 2% of average daily turnover - 77% of the ASX fails this at $20k |
Columns that need explaining
| Part% | your position as a share of average daily dollar turnover. Above 2% you are a meaningful part of the day’s flow and cannot assume a clean exit. |
| ATR% | average true range - how far the stock typically moves in a day, as a % of price. Volatility, not direction: the same number applies to the downside. |
| ATR $ | that range in dollars on your position. Not expected profit. ATR measures the day’s high-to-low range, while a typical close-to-close move is much smaller - QAN has ATR 2.1% but a median day of 0.75%. Read it as “is there enough movement to be worth transacting?” |
| Score | Two components, both measured rather than reasoned: low 5-day relative strength and bearish Wyckoff phase. The original eight-component version was tested over 5,101 observations and ranked worse than random (top decile −0.29%, bottom +0.28%, t=−3.33). Only those two had individual signal, and both pointed the other way, so they were flipped and the rest dropped - six components and 50 of 108 weight points were doing nothing. Inverted: top decile +0.31% vs bottom −0.41%, t=+4.56. This ranks short-term WEAKNESS, not strength - it is a mean-reversion screen. Hover a row for the breakdown. Liquidity is deliberately excluded - it decides whether a trade is takeable, not whether it will rise, which is why the position slider re-filters without re-ranking. |
| Conf | model confidence in the trend read. Green = High, which is rare. |
Trade levels - derived, not forecast
| Entry | a quarter-ATR below last price: buy the day’s mid rather than chase the close |
| Stop | the lower of (support − ¼ ATR) and (entry − 1 ATR). Floored at a full ATR because support usually resolves to VWAP, which sits ~1% from price - a stop that tight is taken out by ordinary noise before the idea has failed, and it inflated R:R to a flattering 4.7:1. |
| Target | entry + 0.75 ATR, never projected through resistance. Measured over 5,101 pick-days: an intraday high reached 1.5 ATR on only 3.4% of them, so the previous setting was decorative. 0.75 ATR is reached 21% of the time; the median move is 0.38 ATR. |
| R:R is below 1 by construction | The most important thing on this page. A stop must sit at least 1 ATR away to survive ordinary noise, but a target reachable in one day cannot exceed ~0.75 ATR. So overnight reward:risk is structurally 0.75 - you are risking more than you can realistically make. At 0.75 you need a ~57% win rate to break even, and the measured up-rate on these picks is about 50%. Read the levels as “where this might plausibly get to before you sell at the close”, not as a system with positive expectancy. A one-day holding period is the binding constraint, not the levels. |
| R:R | reward ÷ risk, capped at 0.75. Read the caution below before using it - the ceiling is structural, not a setting. |
Basis codes - how much to trust a level
S:vwap/R:52wH means support came from VWAP, resistance from the
52-week high.
bbL / bbU | Bollinger lower / upper band - statistical, solid |
ema20 | 20-day moving average - widely watched |
vwap | volume-weighted average price - soft, and it moves during the session |
52wH | 52-week high - strongest, everyone can see it |
atr | weakest - invented. No real level qualified, so a volatility projection was used. On the support side it means price is below its Bollinger band, EMA20 and VWAP: nothing underneath. The stop matters most on exactly these rows. |
R:52wH appears when a stock trades above its upper Bollinger
band - a breakout, where that band would otherwise give a
“resistance” below the current price.
Timing
The list is a daily snapshot; intraday re-runs replace that day’s rows while earlier days stay as history. Today’s volume feeds the score and accumulates through the session, so a 10am ranking is genuinely less settled than a 3pm one - the banner above shows how far through a normal day’s volume the data currently is.
Colour coding
Eight columns are graded against the thresholds below. One shared function drives both the table and this list, so they cannot disagree. Green favourable · amber caution · red unfavourable. Anything neutral stays plain, so only decision-relevant cells carry colour.
| Part% | ≤0.5 · 0.5-2 · >2 |
| ATR% | 2.5-6 · 2-2.5 or 6-8 · >8 |
| RSI | 45-65 · >72 or <35 |
| Vol× | ≥2 · <0.8 |
| R:R | ≥0.70 · 0.45-0.70 · <0.45 - the ceiling is 0.75, see below |
| MQS | ≥50 · <25 |
| Conf | High · Medium |
| Phase | not graded - it predicts inversely (see What to look for), and neither colour would be honest |
| Basis | bbL + bbU · contains atr |
D% / W% / M% / Y% are not graded - they keep plain up-down colour, where the sign is the meaning. A green ATR% means “a useful amount of movement”, not “the price rose”; the grading classes are deliberately separate from the ones used for gains and losses so the two are never confused.
What to look for
| Part% < 0.5 | you are a rounding error in the day’s flow - exit whenever you want |
| Basis S:bbL/R:bbU | both levels are real bands rather than projections. About a third of the list. |
| R:R = 1.50 | the maximum. Means resistance is far enough away not to cap the target. |
| ATR% 2-6 | enough daily movement to clear costs, not so much the position becomes unmanageable overnight |
| Vol× ≥ 2 | today’s move has real participation behind it, not drift on thin volume |
| Phase | Reverse your intuition here. Measured over 5,101 observations, bearish phases (Distribution / Downtrend) preceded BETTER next-day returns - this is mean reversion, and it is why the score now rewards them. The column is left uncoloured on purpose: green-for-Downtrend would be dangerous if you hold beyond one session, red would contradict the score. Only valid for a one-day hold, and only while the market keeps mean-reverting. |
| Score and liquid | the combination. A high score you cannot exit is not an opportunity. |
Cautions
| Overnight gaps | Your stop cannot protect you while the market is closed. Price can open straight through it. This is the defining risk of holding overnight and no level on this screen mitigates it - only position size does. |
| High score, thin liquidity | the most common trap here. The ranking ignores liquidity by design, so the top row is regularly untradable - today’s number one sat at 9.1% of daily turnover. Always read Part% next to Score. |
| Very high ATR% | ATR is symmetric. A stock that typically moves 16% a day moves 16% down just as readily, and those names are usually near the price floor where the spread is punishing too. |
| Basis shows atr | no real support qualified - price is below its Bollinger band, EMA20 and VWAP. There is nothing underneath it. |
| RSI > 72 | you are buying after the move and paying for someone else’s gain. Scored as a penalty, not blocked. |
| News flag | an announcement can invalidate every technical level on the row. Read it before acting, never after. |
| Early in the session | volume feeds the score and is still accumulating. Below ~90% maturity the ranking will still move. |
| R:R < 1.5 | resistance is close enough that the upside does not pay for the downside. Skip it whatever the score says - about half the list. |
| Costs | brokerage plus spread on a $20k round trip comes out of a median daily move of roughly $150. Costs are certain; the edge is not. |
Sizing and every decision remain yours. None of this accounts for your circumstances, and none of it is financial advice.
Right-click any row to open it on another tab.
Loading… |
📥 Contact Inbox
Loading…